CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,369,760 | -10.8% | 288,260 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $3,778,898 | -4.9% | 281,168 | +17.4% | 0.00% | 0.0% |
| Q1 2023 | $3,972,369 | -11.0% | 239,588 | -0.2% | 0.00% | -50.0% |
| Q4 2022 | $4,463,499 | +53.6% | 239,973 | +5.9% | 0.00% | +100.0% |
| Q3 2022 | $2,906,000 | +996.6% | 226,525 | +500.1% | 0.00% | – |
| Q2 2022 | $265,000 | -8.3% | 37,751 | +8.4% | 0.00% | – |
| Q1 2022 | $289,000 | +22.5% | 34,834 | 0.0% | 0.00% | – |
| Q4 2021 | $236,000 | +27.6% | 34,834 | 0.0% | 0.00% | – |
| Q3 2021 | $185,000 | +110.2% | 34,834 | +127.1% | 0.00% | – |
| Q2 2021 | $88,000 | -22.8% | 15,341 | -37.7% | 0.00% | – |
| Q1 2021 | $114,000 | +147.8% | 24,624 | +78.9% | 0.00% | – |
| Q4 2020 | $46,000 | +12.2% | 13,767 | 0.0% | 0.00% | – |
| Q3 2020 | $41,000 | -51.2% | 13,767 | -23.8% | 0.00% | – |
| Q2 2020 | $84,000 | +27.3% | 18,056 | +4.8% | 0.00% | – |
| Q1 2020 | $66,000 | -18.5% | 17,222 | -20.1% | 0.00% | – |
| Q4 2019 | $81,000 | -33.1% | 21,557 | -6.0% | 0.00% | – |
| Q3 2019 | $121,000 | +30.1% | 22,928 | -5.2% | 0.00% | – |
| Q2 2019 | $93,000 | +24.0% | 24,188 | +64.1% | 0.00% | – |
| Q1 2019 | $75,000 | +167.9% | 14,738 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | -50.0% | 14,738 | 0.0% | 0.00% | – |
| Q3 2018 | $56,000 | +21.7% | 14,738 | 0.0% | 0.00% | – |
| Q2 2018 | $46,000 | +24.3% | 14,738 | -4.4% | 0.00% | – |
| Q1 2018 | $37,000 | -45.6% | 15,424 | -9.6% | 0.00% | – |
| Q4 2017 | $68,000 | +151.9% | 17,069 | +61.0% | 0.00% | – |
| Q3 2017 | $27,000 | -6.9% | 10,602 | 0.0% | 0.00% | – |
| Q2 2017 | $29,000 | +141.7% | 10,602 | +1.8% | 0.00% | – |
| Q1 2016 | $12,000 | -53.8% | 10,410 | 0.0% | 0.00% | – |
| Q4 2015 | $26,000 | -16.1% | 10,410 | 0.0% | 0.00% | – |
| Q3 2015 | $31,000 | – | 10,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |